 HomeProductsKey IntermediatesBuy Lapatinib Powder Pharmaceutical Intermediate Lapatinib

Contact Supplier

Ms. Caroline

Leave a message

Contact Now

You May Like

Anesthetics Ropivacaine CAS 84057-95-4 with Best Price Contact Now

Sildena Citrat Powder CAS 171599-83-0 Contact Now

1.4-Butanediol Diol 14B Butylene glycol CAS 110-63-4 Contact Now

New bmk glycidate powder CAS 10250-27-8 Contact Now

High Purity CAS 22563-90-2 Ethyl 3-Oxo-2-Phenylbutanoate Contact Now

Nootropics Magnesium Taurate Powder CAS 334824-43-0 Contact Now

Nootropics Galantamine Hydrobromide CAS 69353-21-5 Contact Now

Antidepressants Tianeptine Sulfate CAS 66981-73-5/30123-17-2 Contact Now

 

Buy Lapatinib Powder Pharmaceutical Intermediate Lapatinib

Name: Acetyl Hexapeptide
Uploaded: 2022-12-18T13:43:16+08:00
Description: Lapatinib, a new member of the 4-anilinoquinazoline class of RTK inhibitors (RTKIs), was launched as an oral

$10 - 55 /Gram

10 /Gram (Min. Order)

option:

Lapatinib intermediate

Payment Type:

T/T

Incoterm:

FOB,CIF,Express Delivery

Min. Order:

10 Gram

Transportation:

Ocean,Land,Air,Express

Port:

Shenzhen,Shanghai,Hongkong

Contact Now

 Chat Now

Product Description

Product Attributes
Supply Ability & Additional Information
Packaging & Delivery

< >

Overview

Product Attributes

Model No.: Lapatinib

Brand: Rhine

CAS: 231277-92-2

Shelf Life: 2years

Test Method: HPLC

Packaging: Foil Bag Drum

Grade Standard: Medical Grade

Characteristic: white powder

Assay: 99%

Product Name: Lapatinib

MW: 581.057543

MF: C29H26ClFN4O4S

Supply Ability & Additional Information

Packaging: Foil Bag Drum

Productivity: 50kg/month

Transportation: Ocean,Land,Air,Express

Place of Origin: china

Supply Ability: 50kg/month

Certificate: N/A

HS Code: /

Port: Shenzhen,Shanghai,Hongkong

Payment Type: T/T

Incoterm: FOB,CIF,Express Delivery

Packaging & Delivery

Selling Units:: Gram

Package Type:: Foil Bag Drum

Lapatinib, a new member of the 4-anilinoquinazoline class of RTK inhibitors (RTKIs), was launched as an oral treatment for breast cancer. Lapatinib has dual affinity for EGFR and HER2 tyrosine kinases. It is indicated in combination with capecitabine for treating patients with advanced or metastatic breast cancer whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane, and trastuzumab. Uses: Lapatinib, used in the form of Lapatinib Ditosylate,...

Product Categories : Key Intermediates

Hot Products

Email to this supplier

*Subject:
*To:

Ms. Caroline
*Email:
*Message:

Your message must be between 20-8000 characters